Sheth KN, Albers GW, Saver JL, et al. Intravenous glibenclamide for cerebral oedema after large hemispheric stroke (CHARM): a phase 3, double-blind, placebo-controlled, randomised trial. Lancet Neurol 2024; 23: 1205–13 —In this Article, the CHARM Trial investigators and the appendix have been updated. This correction has been made as of Dec 18, 2024.

中文翻译：

---

对柳叶刀神经 2024 的更正;23: 1205–13


Sheth KN、Albers GW、Saver JL 等人。静脉注射格列本脲治疗大半球中风后脑水肿 （CHARM）：一项 3 期、双盲、安慰剂对照、随机试验。柳叶刀神经 2024;23： 1205–13 —在本文中，CHARM 试验调查人员和附录已更新。此更正已于 2024 年 12 月 18 日进行。